Literature DB >> 17301631

Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

Judith A Troughton1, Jayne V Woodside, Ian S Young, Dominique Arveiler, Philippe Amouyel, Jean Ferrières, Pierre Ducimetière, Chris C Patterson, Frank Kee, John W G Yarnell, Alun Evans.   

Abstract

BACKGROUND: Classic coronary heart disease risk factors fail to explain the large coronary heart disease incidence gradient between Northern Ireland and France. The Prospective Epidemiological Study of Myocardial Infarction (PRIME), a multicentre prospective study of 10593 men, aims to investigate novel risk factors in these populations. We tested the hypothesis that higher bilirubin, a bile pigment possessing antioxidant properties, is associated with decreased coronary heart disease risk.
METHODS: Bilirubin was measured in 216 participants who had developed coronary heart disease at 5-year follow-up and in 434 matched controls.
RESULTS: Bilirubin was significantly lower in cases (geometric mean 7.95 micromol/l; interquartile range 5.32-12.33 micromol/l) compared with controls (9.07; 6.16-12.76; P=0.005). Conditional logistic regression, adjusted for classical and putative risk factors, showed a U-shaped pattern, with coronary heart disease risk significantly lower for bilirubin in the third and fourth fifths, compared with the first. Additionally, there was a significant quadratic relationship between coronary heart disease risk and fifths of bilirubin concentration (chi2=6.80, df=2; P=0.035).
CONCLUSIONS: These findings suggest that bilirubin is a novel coronary heart disease risk marker in middle-aged men, with a U-shaped relationship observed between bilirubin concentration and coronary heart disease risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301631     DOI: 10.1097/01.hjr.0000230097.81202.9f

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  30 in total

1.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

Review 2.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

3.  Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin.

Authors:  Marlon Stoeckius; Anna Erat; Tatsuya Fujikawa; Makoto Hiromura; Anna Koulova; Leo Otterbein; Cesario Bianchi; Edda Tobiasch; Yossi Dagon; Frank W Sellke; Anny Usheva
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

4.  Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Authors:  Pernette R W de Sauvage Nolting; D Meeike Kusters; Barbara A Hutten; John J P Kastelein
Journal:  J Lipid Res       Date:  2011-06-23       Impact factor: 5.922

5.  Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men.

Authors:  Rahma Ajja; Duck-Chul Lee; Xuemei Sui; Timothy S Church; N Blair Steven
Journal:  Am J Cardiol       Date:  2011-08-23       Impact factor: 2.778

Review 6.  Hyperbilirubinemia, Hypertension, and CKD: the Links.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

7.  Prognostic value of total bilirubin in patients with angina pectoris undergoing percutaneous coronary intervention.

Authors:  Hai-Mu Yao; De-Liang Shen; Xiao-Yan Zhao; Xiao-Fang Wang; Tong-Wen Sun; Jin-Ying Zhang; Ling Li; Luo-Sha Zhao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

9.  The role of bilirubin and its protective function against coronary heart disease.

Authors:  A Erkan; B Ekici; M Uğurlu; G Iş; R Seker; S Demirtaş; S Korkmaz
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

10.  Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004.

Authors:  Todd S Perlstein; Reena L Pande; Mark A Creager; Jennifer Weuve; Joshua A Beckman
Journal:  Am J Med       Date:  2008-09       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.